ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.740
-0.020 (-0.53%)
At close: Apr 28, 2026, 4:00 PM EDT
3.770
+0.030 (0.80%)
After-hours: Apr 28, 2026, 4:00 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$421,539
Profits / Employee
-$738,979
Market Cap
475.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Lyell Immunopharma | 300 |
| 4D Molecular Therapeutics | 196 |
| Verastem | 102 |
| Upstream Bio | 75 |
| Armata Pharmaceuticals | 60 |
| Fulcrum Therapeutics | 55 |
| Candel Therapeutics | 55 |
ADCT News
- 1 day ago - ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026 - PRNewsWire
- 27 days ago - ADC Therapeutics Announces New Employee Inducement Grant - PRNewsWire
- 5 weeks ago - ADC Therapeutics Transcript: H.C. Wainwright Home Series - Transcripts
- 7 weeks ago - ADC Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update - PRNewsWire
- 2 months ago - ADC Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 - PRNewsWire
- 2 months ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire